Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies.

Resteghini, C; Cavalieri, ; Stefano, ; Rametta, ; Alessandro, ; Alfieri, ; Salvatore, ; Galbiati, ; Donata, ; Platini, ; Francesca, ; Locati, ; Laura, Deborah; Bossi, ; Paolo, ; Bergamini, ; Cristiana, ; Granata, ; Roberta, ; Orlandi, ; Ester, ; Piazza, ; Cesare, ; Mancinelli, ; Moela, ; Licitra, ; Lisa, F.